CHAMPION-AF: A Win for Watchman FLX, but With Caveats - TCTMD.com

CHAMPION-AF: A Win for Watchman FLX, but With Caveats  TCTMD.comCHAMPION-AF: Left Atrial Appendage Closure vs. Anticoagulation For AFib  American College of CardiologyNew Frontiers in AFib: Heart Device Noninferior to Blood Thinners in Stroke Prevention, Wins on Safety  Pharmacy TimesSix Reasons Why CHAMPION-AF Should Not Change Practice  MedscapeCHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints  PR Newswire